Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Allen & Hanburys Ltd
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 17/01/2012
PIL Serevent Evohaler

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 24/08/2011 and displayed until 17/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 15/07/2010 and displayed until 24/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 06/01/2010 and displayed until 15/07/2010
Reasons for adding or updating:
  • Change to instructions about overdose
Updated on 30/03/2009 and displayed until 06/01/2010
Reasons for adding or updating:
  • Change to drug interactions
Updated on 08/08/2007 and displayed until 30/03/2009
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
Updated on 04/01/2006 and displayed until 08/08/2007
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  salmeterol xinafoate